Global Biosimilar Market Growth (Status and Outlook) 2022-2028
- LP 4864280
- 104 Pages
- February 2022
- Pharmaceuticals
The United States Biosimilar market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilar market, reaching US$ million by the year 2028. As for the Europe Biosimilar landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biosimilar players cover AET BioTech, Amgen, Boehringer Ingelheim, and Coherus Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Tablet
Oral Solution
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Market Size 2017-2028
2.1.2 Biosimilar Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biosimilar Segment by Type
2.2.1 Tablet
2.2.2 Oral Solution
2.3 Biosimilar Market Size by Type
2.3.1 Biosimilar Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Biosimilar Market Size Market Share by Type (2017-2022)
2.4 Biosimilar Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Biosimilar Market Size by Application
2.5.1 Biosimilar Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Biosimilar Market Size Market Share by Application (2017-2022)
3 Biosimilar Market Size by Player
3.1 Biosimilar Market Size Market Share by Players
3.1.1 Global Biosimilar Revenue by Players (2020-2022)
3.1.2 Global Biosimilar Revenue Market Share by Players (2020-2022)
3.2 Global Biosimilar Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biosimilar by Regions
4.1 Biosimilar Market Size by Regions (2017-2022)
4.2 Americas Biosimilar Market Size Growth (2017-2022)
4.3 APAC Biosimilar Market Size Growth (2017-2022)
4.4 Europe Biosimilar Market Size Growth (2017-2022)
4.5 Middle East & Africa Biosimilar Market Size Growth (2017-2022)
5 Americas
5.1 Americas Biosimilar Market Size by Country (2017-2022)
5.2 Americas Biosimilar Market Size by Type (2017-2022)
5.3 Americas Biosimilar Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Market Size by Region (2017-2022)
6.2 APAC Biosimilar Market Size by Type (2017-2022)
6.3 APAC Biosimilar Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilar by Country (2017-2022)
7.2 Europe Biosimilar Market Size by Type (2017-2022)
7.3 Europe Biosimilar Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar by Region (2017-2022)
8.2 Middle East & Africa Biosimilar Market Size by Type (2017-2022)
8.3 Middle East & Africa Biosimilar Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biosimilar Market Forecast
10.1 Global Biosimilar Forecast by Regions (2023-2028)
10.1.1 Global Biosimilar Forecast by Regions (2023-2028)
10.1.2 Americas Biosimilar Forecast
10.1.3 APAC Biosimilar Forecast
10.1.4 Europe Biosimilar Forecast
10.1.5 Middle East & Africa Biosimilar Forecast
10.2 Americas Biosimilar Forecast by Country (2023-2028)
10.2.1 United States Biosimilar Market Forecast
10.2.2 Canada Biosimilar Market Forecast
10.2.3 Mexico Biosimilar Market Forecast
10.2.4 Brazil Biosimilar Market Forecast
10.3 APAC Biosimilar Forecast by Region (2023-2028)
10.3.1 China Biosimilar Market Forecast
10.3.2 Japan Biosimilar Market Forecast
10.3.3 Korea Biosimilar Market Forecast
10.3.4 Southeast Asia Biosimilar Market Forecast
10.3.5 India Biosimilar Market Forecast
10.3.6 Australia Biosimilar Market Forecast
10.4 Europe Biosimilar Forecast by Country (2023-2028)
10.4.1 Germany Biosimilar Market Forecast
10.4.2 France Biosimilar Market Forecast
10.4.3 UK Biosimilar Market Forecast
10.4.4 Italy Biosimilar Market Forecast
10.4.5 Russia Biosimilar Market Forecast
10.5 Middle East & Africa Biosimilar Forecast by Region (2023-2028)
10.5.1 Egypt Biosimilar Market Forecast
10.5.2 South Africa Biosimilar Market Forecast
10.5.3 Israel Biosimilar Market Forecast
10.5.4 Turkey Biosimilar Market Forecast
10.5.5 GCC Countries Biosimilar Market Forecast
10.6 Global Biosimilar Forecast by Type (2023-2028)
10.7 Global Biosimilar Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AET BioTech
11.1.1 AET BioTech Company Information
11.1.2 AET BioTech Biosimilar Product Offered
11.1.3 AET BioTech Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AET BioTech Main Business Overview
11.1.5 AET BioTech Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Biosimilar Product Offered
11.2.3 Amgen Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Biosimilar Product Offered
11.3.3 Boehringer Ingelheim Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Coherus Biosciences
11.4.1 Coherus Biosciences Company Information
11.4.2 Coherus Biosciences Biosimilar Product Offered
11.4.3 Coherus Biosciences Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Coherus Biosciences Main Business Overview
11.4.5 Coherus Biosciences Latest Developments
11.5 Fujifilm Kyowa Kirin Biologics
11.5.1 Fujifilm Kyowa Kirin Biologics Company Information
11.5.2 Fujifilm Kyowa Kirin Biologics Biosimilar Product Offered
11.5.3 Fujifilm Kyowa Kirin Biologics Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Fujifilm Kyowa Kirin Biologics Main Business Overview
11.5.5 Fujifilm Kyowa Kirin Biologics Latest Developments
11.6 LG Life Sciences/Mochida Pharmaceutical
11.6.1 LG Life Sciences/Mochida Pharmaceutical Company Information
11.6.2 LG Life Sciences/Mochida Pharmaceutical Biosimilar Product Offered
11.6.3 LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 LG Life Sciences/Mochida Pharmaceutical Main Business Overview
11.6.5 LG Life Sciences/Mochida Pharmaceutical Latest Developments
11.7 Momenta Pharmaceuticals
11.7.1 Momenta Pharmaceuticals Company Information
11.7.2 Momenta Pharmaceuticals Biosimilar Product Offered
11.7.3 Momenta Pharmaceuticals Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Momenta Pharmaceuticals Main Business Overview
11.7.5 Momenta Pharmaceuticals Latest Developments
11.8 Oncobiologics
11.8.1 Oncobiologics Company Information
11.8.2 Oncobiologics Biosimilar Product Offered
11.8.3 Oncobiologics Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Oncobiologics Main Business Overview
11.8.5 Oncobiologics Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Biosimilar Product Offered
11.9.3 Pfizer Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Samsung Bioepsis
11.10.1 Samsung Bioepsis Company Information
11.10.2 Samsung Bioepsis Biosimilar Product Offered
11.10.3 Samsung Bioepsis Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Samsung Bioepsis Main Business Overview
11.10.5 Samsung Bioepsis Latest Developments
11.11 Sandoz
11.11.1 Sandoz Company Information
11.11.2 Sandoz Biosimilar Product Offered
11.11.3 Sandoz Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sandoz Main Business Overview
11.11.5 Sandoz Latest Developments
11.12 Zydus Cadila
11.12.1 Zydus Cadila Company Information
11.12.2 Zydus Cadila Biosimilar Product Offered
11.12.3 Zydus Cadila Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Zydus Cadila Main Business Overview
11.12.5 Zydus Cadila Latest Developments
12 Research Findings and Conclusion
Table 1. Biosimilar Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tablet
Table 3. Major Players of Oral Solution
Table 4. Biosimilar Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Biosimilar Market Size Market Share by Type (2017-2022)
Table 7. Biosimilar Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Biosimilar Market Size Market Share by Application (2017-2022)
Table 10. Global Biosimilar Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Biosimilar Revenue Market Share by Player (2020-2022)
Table 12. Biosimilar Key Players Head office and Products Offered
Table 13. Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biosimilar Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Biosimilar Market Size Market Share by Regions (2017-2022)
Table 18. Americas Biosimilar Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Biosimilar Market Size Market Share by Country (2017-2022)
Table 20. Americas Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Biosimilar Market Size Market Share by Type (2017-2022)
Table 22. Americas Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Biosimilar Market Size Market Share by Application (2017-2022)
Table 24. APAC Biosimilar Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Biosimilar Market Size Market Share by Region (2017-2022)
Table 26. APAC Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Biosimilar Market Size Market Share by Type (2017-2022)
Table 28. APAC Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Biosimilar Market Size Market Share by Application (2017-2022)
Table 30. Europe Biosimilar Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Biosimilar Market Size Market Share by Country (2017-2022)
Table 32. Europe Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Biosimilar Market Size Market Share by Type (2017-2022)
Table 34. Europe Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Biosimilar Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Biosimilar Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Biosimilar Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Biosimilar Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Biosimilar Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Biosimilar
Table 43. Key Market Challenges & Risks of Biosimilar
Table 44. Key Industry Trends of Biosimilar
Table 45. Global Biosimilar Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Biosimilar Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Biosimilar Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Biosimilar Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Biosimilar Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Biosimilar Market Size Market Share Forecast by Application (2023-2028)
Table 51. AET BioTech Details, Company Type, Biosimilar Area Served and Its Competitors
Table 52. AET BioTech Biosimilar Product Offered
Table 53. AET BioTech Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AET BioTech Main Business
Table 55. AET BioTech Latest Developments
Table 56. Amgen Details, Company Type, Biosimilar Area Served and Its Competitors
Table 57. Amgen Biosimilar Product Offered
Table 58. Amgen Main Business
Table 59. Amgen Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Amgen Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Biosimilar Area Served and Its Competitors
Table 62. Boehringer Ingelheim Biosimilar Product Offered
Table 63. Boehringer Ingelheim Main Business
Table 64. Boehringer Ingelheim Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Boehringer Ingelheim Latest Developments
Table 66. Coherus Biosciences Details, Company Type, Biosimilar Area Served and Its Competitors
Table 67. Coherus Biosciences Biosimilar Product Offered
Table 68. Coherus Biosciences Main Business
Table 69. Coherus Biosciences Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Coherus Biosciences Latest Developments
Table 71. Fujifilm Kyowa Kirin Biologics Details, Company Type, Biosimilar Area Served and Its Competitors
Table 72. Fujifilm Kyowa Kirin Biologics Biosimilar Product Offered
Table 73. Fujifilm Kyowa Kirin Biologics Main Business
Table 74. Fujifilm Kyowa Kirin Biologics Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Fujifilm Kyowa Kirin Biologics Latest Developments
Table 76. LG Life Sciences/Mochida Pharmaceutical Details, Company Type, Biosimilar Area Served and Its Competitors
Table 77. LG Life Sciences/Mochida Pharmaceutical Biosimilar Product Offered
Table 78. LG Life Sciences/Mochida Pharmaceutical Main Business
Table 79. LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. LG Life Sciences/Mochida Pharmaceutical Latest Developments
Table 81. Momenta Pharmaceuticals Details, Company Type, Biosimilar Area Served and Its Competitors
Table 82. Momenta Pharmaceuticals Biosimilar Product Offered
Table 83. Momenta Pharmaceuticals Main Business
Table 84. Momenta Pharmaceuticals Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Momenta Pharmaceuticals Latest Developments
Table 86. Oncobiologics Details, Company Type, Biosimilar Area Served and Its Competitors
Table 87. Oncobiologics Biosimilar Product Offered
Table 88. Oncobiologics Main Business
Table 89. Oncobiologics Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Oncobiologics Latest Developments
Table 91. Pfizer Details, Company Type, Biosimilar Area Served and Its Competitors
Table 92. Pfizer Biosimilar Product Offered
Table 93. Pfizer Main Business
Table 94. Pfizer Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Pfizer Latest Developments
Table 96. Samsung Bioepsis Details, Company Type, Biosimilar Area Served and Its Competitors
Table 97. Samsung Bioepsis Biosimilar Product Offered
Table 98. Samsung Bioepsis Main Business
Table 99. Samsung Bioepsis Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Samsung Bioepsis Latest Developments
Table 101. Sandoz Details, Company Type, Biosimilar Area Served and Its Competitors
Table 102. Sandoz Biosimilar Product Offered
Table 103. Sandoz Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Sandoz Main Business
Table 105. Sandoz Latest Developments
Table 106. Zydus Cadila Details, Company Type, Biosimilar Area Served and Its Competitors
Table 107. Zydus Cadila Biosimilar Product Offered
Table 108. Zydus Cadila Main Business
Table 109. Zydus Cadila Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Zydus Cadila Latest Developments
List of Figures
Figure 1. Biosimilar Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilar Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Biosimilar Market Size Market Share by Type in 2021
Figure 7. Biosimilar in Hospital Pharmacy
Figure 8. Global Biosimilar Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Biosimilar in Retail Pharmacy
Figure 10. Global Biosimilar Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Biosimilar in Online Pharmacy
Figure 12. Global Biosimilar Market: Online Pharmacy (2017-2022) & ($ Millions)
Figure 13. Global Biosimilar Market Size Market Share by Application in 2021
Figure 14. Global Biosimilar Revenue Market Share by Player in 2021
Figure 15. Global Biosimilar Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Biosimilar Market Size 2017-2022 ($ Millions)
Figure 17. APAC Biosimilar Market Size 2017-2022 ($ Millions)
Figure 18. Europe Biosimilar Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Biosimilar Market Size 2017-2022 ($ Millions)
Figure 20. Americas Biosimilar Value Market Share by Country in 2021
Figure 21. Americas Biosimilar Consumption Market Share by Type in 2021
Figure 22. Americas Biosimilar Market Size Market Share by Application in 2021
Figure 23. United States Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Biosimilar Market Size Market Share by Region in 2021
Figure 28. APAC Biosimilar Market Size Market Share by Application in 2021
Figure 29. China Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Biosimilar Market Size Market Share by Country in 2021
Figure 36. Europe Biosimilar Market Size Market Share by Type in 2021
Figure 37. Europe Biosimilar Market Size Market Share by Application in 2021
Figure 38. Germany Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Biosimilar Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Biosimilar Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Biosimilar Market Size Market Share by Application in 2021
Figure 46. Egypt Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Biosimilar Market Size 2023-2028 ($ Millions)
Figure 52. APAC Biosimilar Market Size 2023-2028 ($ Millions)
Figure 53. Europe Biosimilar Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Biosimilar Market Size 2023-2028 ($ Millions)
Figure 55. United States Biosimilar Market Size 2023-2028 ($ Millions)
Figure 56. Canada Biosimilar Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Biosimilar Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Biosimilar Market Size 2023-2028 ($ Millions)
Figure 59. China Biosimilar Market Size 2023-2028 ($ Millions)
Figure 60. Japan Biosimilar Market Size 2023-2028 ($ Millions)
Figure 61. Korea Biosimilar Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Biosimilar Market Size 2023-2028 ($ Millions)
Figure 63. India Biosimilar Market Size 2023-2028 ($ Millions)
Figure 64. Australia Biosimilar Market Size 2023-2028 ($ Millions)
Figure 65. Germany Biosimilar Market Size 2023-2028 ($ Millions)
Figure 66. France Biosimilar Market Size 2023-2028 ($ Millions)
Figure 67. UK Biosimilar Market Size 2023-2028 ($ Millions)
Figure 68. Italy Biosimilar Market Size 2023-2028 ($ Millions)
Figure 69. Russia Biosimilar Market Size 2023-2028 ($ Millions)
Figure 70. Spain Biosimilar Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Biosimilar Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Biosimilar Market Size 2023-2028 ($ Millions)
Figure 73. Israel Biosimilar Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Biosimilar Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Biosimilar Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
